Lifevantage (NASDAQ:LFVN) Shares Pass Below Two Hundred Day Moving Average - Here's What Happened

Key Points

• Shares fell below its 200-day moving average, trading as low as $4.08 and last at $4.35 versus a 200-day SMA of $6.22; the stock's 50-day SMA is $4.65, market cap is $55.72M and P/E is 7.25.
• Lifevantage missed quarterly expectations, reporting $0.15 EPS versus a $0.22 consensus and $48.93M in revenue versus $54.40M, and set FY2026 guidance at 0.600–0.800 EPS.
• Insider buying occurred—Director Judd Dayton bought 10,500 shares at about $4.53—and the company pays a quarterly dividend of $0.045 (annualized yield 4.1%, DPR 30%).

Lifevantage Corporation (NASDAQ:LFVN - Get Free Report)'s share price crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $6.22 and traded as low as $4.08. Lifevantage shares last traded at $4.35, with a volume of 137,581 shares.

Analysts Set New Price Targets

A number of analysts have recently weighed in on the stock. Weiss Ratings reiterated a "hold (c)" rating on shares of Lifevantage in a report on Friday, March 27th. Lake Street Capital reissued a "buy" rating on shares of Lifevantage in a research note on Thursday, February 5th. Finally, Loop Capital set a $5.00 price target on shares of Lifevantage in a research note on Thursday, February 5th. One research analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the company's stock. According to data from MarketBeat, Lifevantage currently has an average rating of "Moderate Buy" and an average price target of $5.00.

Lifevantage Price Performance

The stock's 50 day simple moving average is $4.65 and its two-hundred day simple moving average is $6.22. The firm has a market cap of $55.72 million, a P/E ratio of 7.25 and a beta of 0.36.

Lifevantage (NASDAQ:LFVN - Get Free Report) last announced its quarterly earnings results on Wednesday, February 4th. The company reported $0.15 earnings per share for the quarter, missing the consensus estimate of $0.22 by ($0.07). The firm had revenue of $48.93 million for the quarter, compared to the consensus estimate of $54.40 million. Lifevantage had a net margin of 3.74% and a return on equity of 29.59%. Lifevantage has set its FY 2026 guidance at 0.600-0.800 EPS.

Lifevantage Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, March 16th. Investors of record on Monday, March 2nd were given a dividend of $0.045 per share. The ex-dividend date of this dividend was Monday, March 2nd. This represents a $0.18 annualized dividend and a dividend yield of 4.1%. Lifevantage's dividend payout ratio (DPR) is 30.00%.

Insider Buying and Selling at Lifevantage

In other news, Director Judd Dayton purchased 10,500 shares of Lifevantage stock in a transaction that occurred on Monday, March 2nd. The stock was bought at an average price of $4.53 per share, with a total value of $47,565.00. Following the completion of the transaction, the director directly owned 80,359 shares of the company's stock, valued at approximately $364,026.27. The trade was a 15.03% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders have purchased a total of 38,207 shares of company stock worth $178,585 over the last ninety days. 21.95% of the stock is owned by company insiders.

Institutional Investors Weigh In On Lifevantage

Several institutional investors and hedge funds have recently made changes to their positions in LFVN. Cubist Systematic Strategies LLC bought a new stake in shares of Lifevantage during the first quarter valued at approximately $97,000. Jones Financial Companies Lllp boosted its holdings in Lifevantage by 14,484.0% in the first quarter. Jones Financial Companies Lllp now owns 29,168 shares of the company's stock worth $425,000 after purchasing an additional 28,968 shares during the last quarter. Goldman Sachs Group Inc. boosted its holdings in Lifevantage by 24.5% in the first quarter. Goldman Sachs Group Inc. now owns 44,518 shares of the company's stock worth $649,000 after purchasing an additional 8,762 shares during the last quarter. Jane Street Group LLC boosted its holdings in Lifevantage by 5.4% in the first quarter. Jane Street Group LLC now owns 36,567 shares of the company's stock worth $533,000 after purchasing an additional 1,877 shares during the last quarter. Finally, Geode Capital Management LLC boosted its holdings in Lifevantage by 106.1% in the second quarter. Geode Capital Management LLC now owns 245,332 shares of the company's stock worth $3,210,000 after purchasing an additional 126,274 shares during the last quarter. Institutional investors own 35.32% of the company's stock.

About Lifevantage

LifeVantage Corporation is a publicly traded company that develops, markets and distributes nutritional supplements, skincare products and weight-management solutions through a direct-selling business model. The company's flagship offering, Protandim®, is formulated to activate the Nrf2 pathway, which is associated with cellular defense processes. LifeVantage also markets the PhysIQ® line for metabolism and body composition support and the TrueScience® skincare regimen, targeting a range of health and wellness needs.

Founded in 1999 and headquartered in Sandy, Utah, LifeVantage combines research in nutrigenomics with a network of independent distributors to bring its products to market.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.